3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
4
Seizures
3
Lennox Gastaut Syndrome
3
Epilepsies, Myoclonic
3
Anxiety Disorders
2
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Prostatic Neoplasms
1
Parasomnias
1
Pain
1
Neoplasms
1
Nausea
1
Marijuana Abuse
1
Liver Cirrhosis
1
Glioblastoma
1
Epilepsy
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chemotherapy-Induced Peripheral Neuropathy
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Pain
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Behavior
1
Interventions
resiniferatoxin
1
cannabichromene
1
Transcutaneous Electric Nerve Stimulation
1
Transcranial Direct Current Stimulation
1
Tramadol
1
Therapeutic Touch
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Spinal Cord Stimulation
1
Radiosurgery
1
Pharmacogenomic Testing
1
Patient Education as Topic
1
Pain Management
1
Oxycodone
1
Nerve Growth Factor
1
Midazolam
1
Massage
1
Lidocaine
1
Laser Therapy
1
Electroacupuncture
1
Duloxetine Hydrochloride
1
Dronabinol
1
Control Groups
1
Cognitive Behavioral Therapy
1
Cannabidiol
1
Art Therapy
1
Antibodies
1
Acupuncture Therapy
1
Acupressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cancer Pain
×
Cannabidiol
×
1 year
×
Clear all
NCT06533657
2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2
Completed
11 enrolled